MustGrow Biologics Corp.
MGROF
$0.32
-$0.02-6.58%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 36.82% | 14.64% | -124.13% | 31.14% | -31.88% |
| Total Depreciation and Amortization | -- | -1.03% | 1.04% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -195.85% | -34.83% | 940.65% | 109.80% | -9,449.45% |
| Change in Net Operating Assets | -147.06% | -53.26% | 43.83% | 195.47% | -207.34% |
| Cash from Operations | -163.06% | -172.99% | 3.51% | 90.44% | -501.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -100.00% | -- | -100.00% | -- |
| Total Debt Repaid | -- | 95.88% | -2,325.58% | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 41,361.29% | -100.24% | 1,301.20% | -94.90% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.81% | -259.87% | 833.29% | 78.77% | -65.61% |